HOME
ABOUT
PORTFOLIO
_
TEAM
NEWS
CONTACT
More
Use of plant microbiome to improve yield in high stress environments
VIR -- initial public offering October, 2019
GOSS -- initial public offering February, 2019
GRTS -- initial public offering September, 2018
EFTR -- initial public offering August, 2021
Acquired by Pacific Biosciences (PACB) -- July, 2021
G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications
Harnessing the regulatory genome to create next-generation molecular therapies
DICE -- initial public offering September, 2021
EBR:ASX -- initial public offering November, 2021
UBX -- initial public offering May, 2018
Acquired by Neumora Therapeutics
Merged with Tempest Therapeutics (Nasdaq: TPST), June 2021
PULM -- reverse merger June, 2015
SNNA -- initial public offering July, 2017